NBGEX | VEXRX | NBGEX / VEXRX | |
Total Expense Ratio | 1.09 | 0.33 | 330% |
Annual Report Gross Expense Ratio | 1.09 | 0.33 | 330% |
Fund Existence | 32 years | 24 years | - |
Gain YTD | -4.165 | 4.764 | -87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 50000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.71B | 20.6B | 42% |
Annual Yield % from dividends | 0.00 | 0.49 | - |
Returns for 1 year | -10.45 | -3.21 | 326% |
Returns for 3 years | 4.73 | 25.94 | 18% |
Returns for 5 years | -4.09 | 3.55 | -115% |
Returns for 10 years | 8.62 | 34.47 | 25% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNSX | 71.60 | 0.44 | +0.62% |
Janus Henderson Global Life Sciences S | |||
SSCOX | 6.15 | 0.03 | +0.49% |
Touchstone Small Company C | |||
GSMVX | 16.78 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity Instl | |||
CLBFX | 38.87 | 0.04 | +0.10% |
American Funds American Balanced 529F | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst |